Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, multi-cohort clinical trial
SMET12联合托瑞普利单抗和化疗治疗EGFR蛋白阳性、初治或对标准疗法产生耐药性的晚期非小细胞肺癌患者的疗效和安全性:一项II期多队列临床试验
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1706961
Lin, Jinghui; Chen, Shanshan; Li, Meifang; Weng, Lihong; Xu, Haipeng; Wang, Qiang; Zhang, Jing; Lin, Dong; Wang, Haipo; Liu, Qinying; He, Zhiyong